This study is currently recruiting.
Description: This is a clinical research study of a medication that may treat both anxiety and epilepsy. The study will be for 16 weeks with 11 study visits.
Eligibility & Criteria
IRB #: 00282248
Principal Investigator: Jay Salpekar, MD
Eligible Age Range: Ages 6 to 17
Diagnosis: Children and adolescents with seizures who often are nervous or afraid.
Contact Information: Call the Clinical Trials Unit at Kennedy Krieger Institute at 443-923-3850 or email ResearchTrials@KennedyKrieger.org
Click here to view study flyer.